If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2020

Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group

Mora, B., Guglielmelli, P., Rumi, E., Maffioli, M., Barraco, D., Rambaldi, A., Caramella, M., Komrokji, R. S., Kiladjian, J. J., Gotlib, J., Iurlo, A., Cervantes, F., Devos, T., Palandri, F., De Stefano, V., Ruggeri, M., Silver, R. T., Albano, F., Benevolo, G., Cavalloni, C. & 10 others, Uccella, S., Accetta, R., Siracusa, C., Agnoli, S., Merli, M., Barbui, T., Bertù, L., Cazzola, M., Vannucchi, A. M. & Passamonti, F., 2020, In : American Journal of Hematology. 95, 1, p. E1-E3

Research output: Contribution to journalLetter

Open Access

Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study

Rambaldi, A., Iurlo, A., Vannucchi, A. M., Noble, R., von Bubnoff, N., Guarini, A., Martino, B., Pezzutto, A., Carli, G., De Muro, M., Luciani, S., McMullin, M. F., Cambier, N., Marolleau, J. P., Mesa, R. A., Tibes, R., Pancrazzi, A., Gesullo, F., Bettica, P., Manzoni, S. & 1 others, Di Tollo, S., Jan 1 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

Open Access
2019

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)

Elli, E. M., Iurlo, A., Aroldi, A., Caramella, M., Malato, S., Casartelli, E., Maffioli, M., Gardellini, A., Carraro, M. C., D'Adda, M., Polverelli, N., Rossi, M., Orofino, N., Carrer, A., Gambacorti-Passerini, C., Antolini, L. & Passamonti, F., Jan 1 2019, In : British Journal of Haematology. 186, 5, p. e123-e126

Research output: Contribution to journalLetter

Open Access

Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy

Tiribelli, M., Abruzzese, E., Capodanno, I., Sorà, F., Trabacchi, E., Iurlo, A., Luciano, L., Binotto, G., Bonifacio, M., Annunziata, M., Crugnola, M. & Fanin, R., 2019, In : Annals of Hematology. 98, 11, p. 2609-2611

Research output: Contribution to journalLetter

Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative

Loscocco, G. G., Mannelli, F., Guglielmelli, P., Paoli, C., Marone, I., Cucci, R., Coltro, G., Sordi, B., Albano, F., Breccia, M., De Stefano, V., Finazzi, G., Iurlo, A., Martino, B., Palandri, F., Passamonti, F., Siragusa, S., Mannelli, L., Fantoni, D., Fazi, P. & 4 others, Amadori, S., Vignetti, M., Barbui, T. & Vannucchi, A. M., Jan 1 2019, In : American Journal of Hematology. 94, 9, p. E239-E242

Research output: Contribution to journalLetter

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

on behalf of MPN-K authors, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia

Iurlo, A., Bucelli, C., Cattaneo, D., Levati, G. V., Viani, B., Tavazzi, D., Consonni, D., Baldini, L. & Cappellini, M. D., Jan 1 2019, In : American Journal of Hematology. 94, 11, p. E283-E285

Research output: Contribution to journalLetter

Open Access

‘Secondary chronic myeloid leukemia’: comparison between patients previously exposed or not to chemo- and/or radiotherapy

Autore, F., Sorà, F., Chiusolo, P., Annunziata, M., Iurlo, A., Cattaneo, D., Galimberti, S., Bajer, J. A. & Sica, S., Jan 1 2019, In : Leukemia and Lymphoma. 60, 14, p. 3584-3586

Research output: Contribution to journalLetter

“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key?

Bernardi, S., Bonifacio, M., Iurlo, A., Zanaglio, C., Tiribelli, M., Binotto, G., Abruzzese, E. & Russo, D., Jan 1 2019, In : European Journal of Haematology. 103, 3, p. 272-273

Research output: Contribution to journalLetter

2018

Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients

Palandri, F., Palumbo, G. A., Bonifacio, M., Breccia, M., Latagliata, R., Martino, B., Polverelli, N., Abruzzese, E., Tiribelli, M., Nicolosi, M., Bergamaschi, M., Tieghi, A., Iurlo, A., Sgherza, N., Cavazzini, F., Isidori, A., Binotto, G., Ibatici, A., Crugnola, M., Heidel, F. & 10 others, Bosi, C., Bartoletti, D., Auteri, G., Catani, L., Cuneo, A., Aversa, F., Semenzato, G., Cavo, M., Vianelli, N. & Benevolo, G., Nov 1 2018, In : Leukemia Research. 74, p. 86-88 3 p.

Research output: Contribution to journalLetter

Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms

Cattaneo, D., Gianelli, U., Bianchi, P., Cortelezzi, A. & Iurlo, A., Jun 1 2018, In : European Journal of Internal Medicine. 52, p. e25-e26

Research output: Contribution to journalLetter

2017

Early detection of pulmonary hypertension in primary myelofibrosis: The role of echocardiography, cardiopulmonary exercise testing, and biomarkers

Sciumè, M., Mattiello, V., Cattaneo, D., Bucelli, C., Orofino, N., Gandolfi, L., Pettine, L., Lonati, S., Gianelli, U., Pierini, A., Cortelezzi, A. & Iurlo, A., Apr 1 2017, In : American Journal of Hematology. 92, 4, p. E47-E48

Research output: Contribution to journalLetter

Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version

Iurlo, A., Gianelli, U., Cattaneo, D., Thiele, J. & Orazi, A., Apr 1 2017, In : American Journal of Hematology. 92, 4, p. E48-E51

Research output: Contribution to journalLetter

2016

Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase

Breccia, M., Abruzzese, E., Iurlo, A., Gozzini, A., Isidori, A., Gangemi, D., Pregno, P. & Alimena, G., May 31 2016, In : Haematologica. 101, 6, p. e267-e268

Research output: Contribution to journalLetter